The global peptic ulcer drugs market, valued at USD 4.3 billion in 2023, is poised for substantial growth, with projections indicating it will reach USD 6.26 billion by 2031. This represents a compound annual growth rate (CAGR) of 4.81% over the forecast period from 2024 to 2031
Key Players
The major players in Peptic Ulcer Drugs Market are AstraZeneca plc, Abbott...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek